Bright Health Group (BHG) Competitors $6.77 +0.00 (+0.07%) As of 07/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock BHG vs. REPL, LRMR, VTYX, CVRX, NLTX, FDMT, OGI, CRGX, MGRM, and SXTCShould you be buying Bright Health Group stock or one of its competitors? The main competitors of Bright Health Group include Replimune Group (REPL), Larimar Therapeutics (LRMR), Ventyx Biosciences (VTYX), CVRx (CVRX), Neoleukin Therapeutics (NLTX), 4D Molecular Therapeutics (FDMT), Organigram Global (OGI), CARGO Therapeutics (CRGX), Monogram Orthopaedics (MGRM), and China SXT Pharmaceuticals (SXTC). These companies are all part of the "medical" sector. Bright Health Group vs. Its Competitors Replimune Group Larimar Therapeutics Ventyx Biosciences CVRx Neoleukin Therapeutics 4D Molecular Therapeutics Organigram Global CARGO Therapeutics Monogram Orthopaedics China SXT Pharmaceuticals Bright Health Group (NYSE:BHG) and Replimune Group (NASDAQ:REPL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment. Which has more volatility & risk, BHG or REPL? Bright Health Group has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Replimune Group has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Does the media prefer BHG or REPL? In the previous week, Replimune Group had 48 more articles in the media than Bright Health Group. MarketBeat recorded 48 mentions for Replimune Group and 0 mentions for Bright Health Group. Replimune Group's average media sentiment score of 0.04 beat Bright Health Group's score of 0.00 indicating that Replimune Group is being referred to more favorably in the news media. Company Overall Sentiment Bright Health Group Neutral Replimune Group Neutral Which has preferable earnings & valuation, BHG or REPL? Replimune Group has lower revenue, but higher earnings than Bright Health Group. Replimune Group is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright Health Group$2.76B0.02-$1.46B-$208.73-0.03Replimune GroupN/AN/A-$247.30M-$3.07-2.48 Is BHG or REPL more profitable? Replimune Group has a net margin of 0.00% compared to Bright Health Group's net margin of -85.40%. Bright Health Group's return on equity of 0.00% beat Replimune Group's return on equity.Company Net Margins Return on Equity Return on Assets Bright Health Group-85.40% N/A -10.26% Replimune Group N/A -57.98%-45.21% Do analysts rate BHG or REPL? Replimune Group has a consensus target price of $7.67, indicating a potential upside of 0.88%. Given Replimune Group's stronger consensus rating and higher probable upside, analysts clearly believe Replimune Group is more favorable than Bright Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Health Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Replimune Group 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.33 Do institutionals and insiders have more ownership in BHG or REPL? 92.5% of Replimune Group shares are owned by institutional investors. 58.4% of Bright Health Group shares are owned by company insiders. Comparatively, 8.8% of Replimune Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryReplimune Group beats Bright Health Group on 10 of the 16 factors compared between the two stocks. Get Bright Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BHG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHG vs. The Competition Export to ExcelMetricBright Health GroupHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$54.08M$54.08M$5.47B$20.69BDividend YieldN/AN/A4.74%3.67%P/E Ratio-0.03N/A28.6729.07Price / Sales0.020.02422.2666.55Price / CashN/AN/A35.4522.84Price / Book-0.27N/A8.274.43Net Income-$1.46B-$1.46B$3.24B$994.22M7 Day Performance0.07%0.07%-3.63%-3.35%1 Month Performance-1.10%-1.10%4.40%-2.06%1 Year Performance1.88%1.88%25.97%10.15% Bright Health Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHGBright Health GroupN/A$6.77+0.1%N/A+3.7%$54.08M$2.76B-0.032,840REPLReplimune Group3.8716 of 5 stars$2.81-77.2%$11.38+304.8%-25.6%$216.61MN/A-0.92210Trending NewsAnalyst UpgradeOptions VolumeGap DownHigh Trading VolumeLRMRLarimar Therapeutics2.246 of 5 stars$3.38+3.7%$18.50+447.3%-58.7%$216.42MN/A-2.2730Positive NewsUpcoming EarningsVTYXVentyx Biosciences3.029 of 5 stars$3.02+2.4%$10.00+231.1%+17.4%$214.90MN/A-1.7330News CoverageShort Interest ↑CVRXCVRx2.6904 of 5 stars$8.07-2.7%$14.50+79.7%-8.9%$210.39M$51.29M-3.70160Upcoming EarningsNLTXNeoleukin TherapeuticsN/A$22.34-1.2%N/A-46.3%$209.95MN/A-7.1890High Trading VolumeFDMT4D Molecular Therapeutics2.513 of 5 stars$4.50+6.1%$29.56+556.8%-62.7%$208.49M$40K-1.42120Upcoming EarningsAnalyst ForecastGap UpOGIOrganigram Global1.144 of 5 stars$1.55+6.2%N/A-15.3%$207.61M$194.09M15.50860News CoverageCRGXCARGO Therapeutics2.0111 of 5 stars$4.49-0.7%$15.40+243.0%-73.1%$207.03MN/A-0.97116High Trading VolumeMGRMMonogram Orthopaedics1.3072 of 5 stars$5.73+0.7%$5.40-5.8%+128.4%$204.50M$370K-12.7328News CoveragePositive NewsSXTCChina SXT Pharmaceuticals0.4878 of 5 stars$1.76+8.3%N/A-80.3%$204.21M$1.82M0.0090Analyst Upgrade Related Companies and Tools Related Companies Replimune Group Alternatives Larimar Therapeutics Alternatives Ventyx Biosciences Alternatives CVRx Alternatives Neoleukin Therapeutics Alternatives 4D Molecular Therapeutics Alternatives Organigram Global Alternatives CARGO Therapeutics Alternatives Monogram Orthopaedics Alternatives China SXT Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHG) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHG Stock Alerts